Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors

E-ISSN： 2212-3970|12|2|148-168

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.12, Iss.2, 2017-06, pp. : 148-168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibody–drug conjugates (ADCs)—new targeted therapies

By Papakonstantinou Georgios

memo - Magazine of European Medical Oncology, Vol. 6, Iss. 4, 2013-12 ,pp. : 223-224

Springer Publishing Company

Access to resources Recommend Favorite

Heterocyclic Drug-polymer Conjugates for Cancer Targeted Drug Delivery

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 11, 2016-10 ,pp. : 1355-1377

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Drug Delivery for Breast Cancer Treatment

Recent Patents on Anti-Cancer Drug Discovery, Vol. 8, Iss. 2, 2013-05 ,pp. : 143-153

Bentham Science Publishers

Access to resources Recommend Favorite

Vasoactive intestinal peptide receptor-based imaging and treatment of tumors (Review)

International Journal of Oncology, Vol. 44, Iss. 4, 2014-01 ,pp. : 1023-1031

Spandidos Publications

Access to resources Recommend Favorite

Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning (Review)

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 1287-1293

Spandidos Publications

Access to resources Recommend Favorite